Milana Pharm
  • Delivery Platform
  • Analgea SR
  • Products
  • Business Development
  • Contact
Select Page
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation

MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation

by admin | Jun 5, 2019

(GLOBE NEWSWIRE) — MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management and pain, announced today that it received a Notice of Allowance from the United States Patent...

Recent Comments

    Archives

    • June 2019
    • March 2018

    Categories

    • News Articles

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2019 Milana Pharm  |  Designed by WebDevil Design  |  Privacy Policy